Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 3/20 | 0.64 |
| ▸ | CES1 | P23141 | 3/20 | 0.59 |
| ▸ | BCHE | P06276 | 2/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | MIF | P14174 | 3/20 | 0.47 |
| ▸ | MAOB | P27338 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 3/20 | 0.44 |
| ▸ | TDP2 | O95551 | 2/20 | 0.44 |
| ▸ | S100A4 | P26447 | 2/20 | 0.44 |
| ▸ | POLB | P06746 | 2/20 | 0.44 |
| ▸ | CES2 | O00748 | 1/20 | 0.44 |
| ▸ | APAF1 | O14727 | 1/20 | 0.44 |
| ▸ | TERT | O14746 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | PLIN1 | O60240 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2319027 | 0.84 | MAOA (0.90) | MAOACES1BCHEALDH1A1CYP1A2 | |
| Anthrone SCHEMBL18143 | 0.79 | MAOA (1.00) | MAOACES1BCHEALDH1A1CYP1A2 | |
| Anthrone SCHEMBL29357010 | 0.79 | MAOA (1.00) | MAOACES1BCHEALDH1A1CYP1A2 | |
| Anthrone SCHEMBL29448801 | 0.79 | MAOA (1.00) | MAOACES1BCHEALDH1A1CYP1A2 | |
| Anthrone SCHEMBL1527782 | 0.79 | MAOA (1.00) | MAOACES1BCHEALDH1A1CYP1A2 | |
| SCHEMBL5809328 | 0.77 | CES1 (0.86) | MAOACES1BCHEALDH1A1CYP1A2 | |
| Anthrone SCHEMBL22574797 | 0.77 | MAOA (0.95) | MAOACES1BCHEALDH1A1CYP1A2 | |
| Anthraquinone SCHEMBL22026730 | 0.77 | MAOA (0.95) | MAOACES1BCHEALDH1A1CYP1A2 | |
| Anthrone SCHEMBL30922196 | 0.77 | MAOA (0.95) | MAOACES1BCHEALDH1A1CYP1A2 | |
| Anthrone SCHEMBL11259824 | 0.77 | MAOA (0.95) | MAOACES1BCHEALDH1A1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4180034-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER COMPRISING NAPHTHOQUINONE-BASED COMPOUND AND IMMUNE CHECKPOINT INHIBITOR AS ACTIVE INGREDIENTS | NADIANBIO Ltd. (KR) | 2023-05-17 | — | — | EP | disclosed |
| US-10155973-B2 | Methods for detecting organisms and enzymatic reactions using raman spectroscopy and aromatic compounds comprising phosphate | SWORD DIAGNOSTICS, INC. (US) | 2018-12-18 | — | — | US | disclosed |
| US-20150218615-A1 | METHODS FOR DETECTING ORGANISMS AND ENZYMATIC REACTIONS USING RAMAN SPECTROSCOPY AND AROMATIC COMPOUNDS COMPRISING PHOSPHATE | SWORD DIAGNOSTICS, INC. (US) | 2015-08-06 | — | — | US | disclosed |
| EP-2553117-A1 | METHODS FOR DETECTING RAMAN SCATTERING USING AROMATIC COMPOUNDS COMPRISING PHOSPHATE AND AT LEAST ONE NON-LASER LIGHT SOURCE | Sword Diagnostics, Inc. (US) | 2013-02-06 | — | — | EP | disclosed |
| WO-2011123386-A1 | METHODS FOR DETECTING RAMAN SCATTERING USING AROMATIC COMPOUNDS COMPRISING PHOSPHATE AND AT LEAST ONE NON-LASER LIGHT SOURCE | KUNDU SAMAR KUMAR (US) | 2011-10-06 | — | — | WO | disclosed |
| WO-2010096260-A1 | METHODS FOR DETECTING ORGANISMS AND ENZYMATIC REACTIONS USING RAMAN SPECTROSCOPY AND AROMATIC COMPOUNDS COMPRISING PHOSPHATE | SWORD DIAGNOSTICS, INC. (US) | 2010-08-26 | — | — | WO | disclosed |
| US-20100041016-A1 | METHODS FOR DETECTING ORGANISMS AND ENZYMATIC REACTIONS USING RAMAN SPECTROSCOPY AND AROMATIC COMPOUNDS COMPRISING PHOSPHATE | SWORD DIAGNOSTICS, INC. | 2010-02-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100041016-A1 | METHODS FOR DETECTING ORGANISMS AND ENZYMATIC REACTIONS USING RAMAN SPECTROSCOPY AND AROMATIC COMPOUNDS COMPRISING PHOSPHATE | PNP, ARSA, PGLS | MAOA 442/4885CES1 931/4885BCHE 719/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.